Project Grant R37CA291976
Award Date
5/12/25
Completion Date
4/30/30
Dollars Obligated
$584K
Federal Agency
National Cancer Institute
Awardee
Sanford Research (E6KZG3MNE1D5)
Federal Grant Program
93.394
Assistance Type
Project Grant
Place of Performance
South Dakota, USA
Similar Awards
This Project Grant award from the National Cancer Institute (CFDA 93.395 - Cancer Treatment Research) supports the development of an engineered prodrug therapy that leverages tumor-associated proteases to selectively deliver potent cytotoxins to cancer cells. The proposed research aims to define the mechanisms of action of this novel anti-cancer strategy, and determine the efficacy, pharmacokinetics, and pharmacodynamics of combining this prodrug therapy with standard-of-care chemotherapy for...
This $612,288 federal Project Grant award from the National Cancer Institute (CFDA 93.396 Cancer Biology Research) supports research by the University of Wisconsin-Madison on the role of elevated collagen I and fibronectin in the ovarian cancer pre-metastatic niche for high-grade serous ovarian cancer (HGSOC). The award, granted on December 11, 2024, will fund this 5-year research project running through November 30, 2029. The University of Wisconsin System, a prominent academic research...
This Project Grant award from the National Cancer Institute's Cancer Biology Research (CFDA 93.396) program will support research to investigate how changes in the pre-metastatic niche (PMN) facilitate breast cancer metastasis. The total award amount is $521,240 over the project period from Sep 1, 2024 to Aug 31, 2029. The research aims to identify critical events within the PMN that enable metastatic tumor cell colonization, promote phenotypic heterogeneity, and contribute to drug resistance....
The National Cancer Institute (NCI) awarded Carnegie Mellon University a $632,300 Project Grant under the Cancer Biology Research program (CFDA 93.396) to develop an integrated ultra-high-throughput 3D volumetric super-resolution imaging system. This system combines a multiscale fluorescence mesoscope with magnify expansion microscopy to enable rapid, large-area 3D imaging with exceptional subcellular detail. The goal is to study the interactions between cancer and immune cells in situ,...
This $577,034 Project Grant award from the National Cancer Institute's Cancer Biology Research program (CFDA 93.396) supports research to investigate the relationship between the physical properties of the metastatic microenvironment and the efficacy of the immune system's mechanosurveillance mechanisms in controlling cancer cell growth. The principal investigators, located at the Sloan-Kettering Institute for Cancer Research and collaborating with researchers at Florida State University and...
This $2,073,138 Project Grant award, funded by the National Cancer Institute (NCI) under the Cancer Biology Research program (CFDA 93.396), is focused on discovering a new class of tumor antigens and T-cell receptors (TCRs) targeting platinum-resistant high-grade serous ovarian carcinoma (HGSOC). The primary awardee, the University of California, Los Angeles (UCLA), will leverage long-read RNA sequencing, immunopeptidomics, and computational epitope prediction to identify cancer-specific peptide...
This $205,700 Project Grant award from the National Cancer Institute (CFDA 93.395 Cancer Treatment Research) to the Sloan-Kettering Institute for Cancer Research supports research aimed at addressing the problem of rapid resistance to targeted therapies in colorectal cancer. The key objectives are to evaluate how intrinsic tumor features modulate the development of resistance, and to test a novel combination therapy approach of DNA repair inhibition and targeted therapy to prevent resistance...
This $214,583 federal Project Grant award from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393) supports research by Tulane University to evaluate the role of the extracellular matrix (ECM) in the progression and treatment resistance of triple-negative breast cancer (TNBC), particularly in African American patient populations. The key objectives are to: 1) Understand how the TNBC ECM composition changes before and after chemotherapy...
This $512,478 Project Grant awarded by the National Cancer Institute under the Cancer Biology Research (CFDA 93.396) program supports the development of a 4D-tunable hydrogel platform to study the impact of the tumor microenvironment on the initiation and progression of colorectal cancer. The University of Washington, the primary awardee, will optimize and characterize advanced light-activated hydrogels to create an accurate microphysiologic model of the colonic architecture. This...
The National Cancer Institute (CFDA 93.396 - Cancer Biology Research) awarded a $392,187 Project Grant to the University of California, San Diego (UCSD) to investigate how the stiffness of the tumor microenvironment in oral squamous cell carcinoma (OSCC) induces "mechanical memory" that contributes to tumor invasion, metastasis, and recurrence. The project aims to elucidate the mechanisms by which OSCC cells acquire and consolidate this mechanical memory, which allows them to recall...